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ABSTRACT 
Resistance of pathogenic micro-organisms to antibiotics is a serious global health 
concern. In this review, research investigating the antimicrobial properties of honeys 
from around the world, against skin relevant microbes is evaluated. A plethora of in 
vitro studies have revealed that honeys from all over the world have potent microbicidal 
activity against dermatologically important microbes.  Moreover, in vitro studies have 
shown that honey can reduce microbial pathogenicity as well as reverse anti-microbial 
resistance. Studies investigating the antimicrobial properties of honey in vivo have been 
more controversial. It is evident that innovative research is required to exploit the anti-
microbial properties of honey for clinical use and to determine the efficacy of honey in 
the treatment of a range of skin disorders with a microbiological aetiology. 
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INTRODUCTION  
In traditional medicine, honey has been recognised around the world for its skin healing 
properties. The ancient Greeks and Egyptians, for example, used topical application of honey 
to treat skin wounds and burns and Persian traditional medicine documented honey as 
effective in the treatment of wounds, eczema and inflammation 
1, 2
.  
Micro-organisms have been associated with the pathophysiology of a range of dermatological 
disorders. Wound infections, for example, are commonly caused by the micro-organisms 
Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli and infection with S. 
aureus is common in atopic dermatitis 
3, 4
. Other examples are Malassezia yeasts which have 
been associated with the skin conditions pityriasis versicolor, seborrheic dermatitis, atopic 
dermatitis and psoriasis 
5
. Conventional treatments for some of these conditions are 
unsatisfactory e.g. corticosteroids cause skin thinning and ultraviolet radiation therapy has 
been associated with the development of skin cancer 
6
. 
Scientists first reported the ability of honey to kill disease causing microbes in the late 1800s 
but with the advent of antibiotics in the early 1900s scientific interest in honey waned (cited 
in Molan, 2001 
7
). Today, with the emergence of antibiotic resistant microbial strains, such as 
Methicillin resistant Staphylococcus aureus (MRSA); a cause of difficult to treat wound 
infections and a global health concern, honey has again caught the attention of medical 
researchers 
7, 8
.  
In clinical practice today, Manuka Honey produced by honey bees (Apis mellifera) collecting 
nectar from the Manuka tree (Leptospermum scoparium) is used topically in the management 
of wound infections 
9
. Products include γ irradiated honey in gels, ointments and impregnated 
dressings. Revamil honey is another medical grade honey commonly used in clinical practice 
for wound care 
10
. It is produced in greenhouses by manufacturers in the Netherlands but 
further details about the origin of the honey have not been disclosed.  
In this review, research findings for the antimicrobial activities of honeys from around the 
world, against skin relevant microbes, are evaluated. Furthermore, the mechanisms of the 
antimicrobial properties of honey are explored. The principle aim was to understand more 
about the therapeutic potential of honey as a treatment for skin diseases with a 
microbiological aetiology. 
 
ANTIMICROBIAL PROPERTIES OF MANUKA HONEY AGAINST SKIN 
RELEVANT MICROBES: IN VITRO STUDIES 
The most widely researched honey, to date, is Manuka honey from New Zealand. Studies 
have shown that Manuka honey has anti-microbial activity in vitro against the most common 
wound infecting micro-organisms, including MRSA, S. aureus, P. aeruginosa and E. coli 
11, 
12
. Manuka honey can also inhibit the growth of Streptococcus pyogenes, a cause of cellulitis, 
impetigo and necrotising fasciitis, and the dermatophyte Trichophyton mentagrophyte; a 
cause of ringworm 
11, 13
. Indeed, Manuka Honey has been shown to inhibit the growth of a 
range of dermatophytes including Epidermophyton floccosum, Microsporum canis, 
Microsporum gypseum, Trichophyton rubrum and Trichophyton tonsurans; indicating that 
honey may be therapeutic in the treatment of Dermatophytosis (Tinea infections) 
13
. Studies 
have reported that Candida albicans is more resistant to Manuka honey than many other 
microbial species 
14, 15
. Manuka honey has also been shown to have anti-viral activity in vitro 
against varicella zoster virus suggesting that honey may be therapeutic for viral skin rashes 
16
. 
The antiviral properties of honey against other skin relevant viruses such as human papilloma 
virus (HPV) may be worth investigating. 
As the antimicrobial activity of honey varies not only between different types of honey but 
also between batches of the same type of honey, Manuka honey is often ascribed a Unique 
Manuka Factor (UMF). The UMF is a measure of the strength of the antibacterial activity of 
the honey against S. aureus and is calculated based on the concentration of a phenol solution 
that gives a similar zone of growth inhibition in a radial diffusion assay as the honey being 
tested. A criticism of the UMF classification is that it is only a measure of activity against S. 
aureus and not other relevant microbes.  
ANTIMICROBIAL ACTIVITY OF HONEYS FROM AROUND THE WORLD 
AGAINST SKIN RELEVANT MICROBES: IN VITRO STUDIES 
A plethora of scientific papers have reported in vitro anti-microbial activity of honeys from 
all over the world; some examples are described in this section.  
Honey produced in South Gondar, Ethiopia, by the bee Apis mellipodae, a stingless bee, is 
used in traditional medicine in Ethiopia to treat a variety of diseases including skin infections 
17
. Using the method of agar well diffusion Andualem (2013) demonstrated that this honey 
inhibited the growth of the wound infecting microbes E. coli and S. aureus with minimal 
inhibitory concentrations (MICs) of 12.5% and 6.25% respectively.  
In a study by Pimentel (2013), honey samples collected from the stingless bee Melipona 
compressipes manaosensis in Manaus, Amazonas, Brazil, were active against E. coli, S. 
aureus, Proteus vulgaris and Klebsiella species 
18
. Using agar well diffusion assays it was 
demonstrated that honey collected during the rainy season inhibited the growth of E. coli only 
in undiluted forms, whilst, honey collected during the dry season inhibited the growth of E. 
coli, S. aureus and a range of other microbes at much more diluted concentrations. These 
results clearly show the influence of seasonality on the anti-bacterial activity of honey. Plant 
derived factors or entomological factors such as the health of the bee colonies could be 
affected by season with consequences for the antimicrobial activity of the honey produced.  
The researchers also compared the ability of honey to inhibit microbial growth by agar well 
diffusion with a broth dilution assay and found that the broth dilution assay was a more 
sensitive method, most likely, due to better movement of the antimicrobial components of 
honey in liquid broth than in agar. Rutin, a flavonoid previously shown to have antibacterial 
activity was identified in the honey by high powered liquid chromatography (HPLC).  
Kuncic et al (2012) reported that Slovenian honeys from diverse floral origins had 
antibacterial activity against E. coli, P. aeruginosa and S. aureus 
19
. Slovenian chestnut and 
pasture honeys were found to be the most active, for example, the MIC of the chestnut honey 
against S. aureus was found to be 2.5%. C. albicans was not inhibited by any of the 
Slovenian honeys tested and Candida parapsilosis and Candida tropicalis were inhibited 
only by honey concentrations higher than 50%.  
In other studies, the growth of C. albicans was inhibited by Jujube honey, a honey obtained 
from bee keepers in Al-baha, Saudi Arabia from bees feeding on the plant Ziziphus jujuba 
and by a mixture of honey, olive oil and beeswax containing multifloral honey from the 
United Arab Emirates 
20, 21
.  Such findings indicate the potential for some honeys being used 
in the treatment of skin disorders caused by C. albicans such as cutaneous candidiasis.  
Tualang honey, obtained from bees (Apis dorsata) feeding on Tualang trees (Koompassia 
excelsa) in the jungles of Malaysia, was found to inhibit the growth of MRSA, S. aureus, S. 
pyogenes, P. aeruginosa and E. coli in a broth dilution assay, with MICs comparable with 
Manuka honey 
11
. 
In 2013, researchers at Queen Margaret University, Edinburgh, Scotland reported the 
antimicrobial activity of a Scottish Honey called Portobello Honey 
22
. Portobello Honey was 
produced by honey bees in an apple orchard in Portobello, Edinburgh, Scotland. Five 
concentrations of the Portobello Honey and medical grade Manuka Honey (0, 1, 10, 50 and 
70%) were tested against S. aureus, P. aeuginosa and E. Coli using agar disc diffusion and a 
broth dilution assay. The agar disc diffusion method did not demonstrate any antimicrobial 
activity of the honeys tested however it was reported that the honey remained on the surface 
of the disc and did not diffuse into the agar. The broth dilution assay, on the other hand, 
demonstrated antimicrobial activity of Portobello Honey and Manuka Honey at 
concentrations of 50 and 70% which were found to inhibit the majority of all of the bacterial 
species tested. The MIC of Portobello Honey was not calculated but the authors concluded 
that honey is a superior antibacterial agent.  
In a study by Carnwath et al (2014), the anti-microbial activities of a selection of 10 honeys 
against 10 microorganisms were tested at the department of Veterinary Medicine, University 
of Glasgow, Scotland 
23
. The honeys tested included medical grade and shop bought Manuka 
honeys, Scottish Heather Honey (from a local bee keeper), Blossom Honey, Vipers Bugloss 
Honey, Inverness Floral Honey and Glasgow Floral Honey. The microorganisms tested 
included MRSA, S. aureus, E. coli, P. aeruginosa and Acinetobacter baumannii. Serial 
dilutions of the honeys were prepared in distilled water and mixed with equal volumes of 
nutrient agar to give final honey concentrations ranging from 2-16%. Plates were inoculated 
with the appropriate microorganism and incubated aerobically overnight.  All the honeys 
tested demonstrated antimicrobial activity but the most active was found to be the Scottish 
Heather Honey which inhibited the growth of all the micro-organisms tested with MICs 
ranging from <2% to 6%. The Scottish Heather Honey was even more active than all of the 
Manuka honeys used in the study.  
Remarkably, in vitro research has also shown that honey can actually reverse antibiotic 
resistance, suggesting that honey used in combination with antibiotics may have additional 
therapeutic effects 
24
. A suggested mechanism is via honey induced down-regulation of 
mecR1 gene product, a transducer associated with antibiotic resistance in MRSA.   Indeed, 
Muller et al (2013) reported that Manuka honey worked synergistically with the antibiotic 
Rifampicin to inhibit the growth of MRSA and clinical isolates of S. aureus 
25
. 
The evidence is clear that, in a laboratory setting, honeys from all over the world have potent 
antimicrobial activity against skin relevant microbes. Indeed, the antimicrobial activity of 
honey from Iran has been shown to be comparable with the sulphonamide family of 
antibiotics 
26
. The micro-organism S. aureus is clearly inhibited by honeys of different floral 
origins. As well as wound infections, S. aureus is an important cause of boils, furuncles, styes 
and impetigo.  Honeys have broad spectrum anti-microbial properties and it may be that 
honey has therapeutic value in the treatment of other skin disorders in which microbes have 
been associated with the aetiology of the disease, as well as those disorders that are 
commonly treated with topical antibiotics e.g. acne. Analysis of the antimicrobial activity of 
different types of honey against other dermatologically relevant microbes should be 
encouraged.  
Table 1. Activity of some honeys from around the world against common skin relevant 
microbes.  
Type of 
Honey 
MRSA S. 
aureus 
P. 
aeruginosa 
E. 
coli 
C. 
albicans 
Dermatophytes 
 
Malassezia 
species 
HPV 
Manuka 
Honey 
1 
     + 
(12) 
      + 
(11) 
       + 
(11,12) 
   + 
(11,12) 
    - 
(14,15)  
         +         
(13)             
      Ϯ Ϯ 
Scottish 
Heather 
Honey 
2 
     + 
(23) 
      +  
(23) 
       +  
(23) 
   + 
(23) 
    Ϯ          Ϯ       Ϯ Ϯ 
Portobello 
Honey 
2 
     Ϯ      +  
(22) 
        +   
(22) 
  + 
(22) 
    Ϯ          Ϯ       Ϯ Ϯ 
Tualang 
Honey 
3 
   + 
(11) 
      +     
(11, 27) 
        + 
(11, 27) 
  + 
(11, 27) 
    Ϯ           Ϯ        Ϯ Ϯ 
 
Key:  + active, - not active or low activity, Ϯ unknown.  1 New Zealand, 2 Scotland, 3 Malaysia. (Numbers in brackets are references)   
 
ANTIMICROBIAL PROPERTIES OF HONEY: IN VIVO HUMAN STUDIES 
The majority of studies to date have demonstrated the antimicrobial activity of honey against 
a range of microbial strains including clinical isolates, using in vitro antimicrobial assays. 
Fewer studies have demonstrated the antimicrobial activity of honey in vivo; those studies 
that have been carried out have mainly investigated the antimicrobial activity of honey in 
relation to wound infections. In the first decade of the 21
st
 Century, several case studies 
involving wound patients produced optimistic findings. A brief report by Cooper et al (2001) 
described how treatment of a S. aureus infected, recalcitrant surgical wound in a 38 year old 
female with Manuka honey impregnated dressings and oral co-amoxiclav resulted in 
significant healing of the wound and bacterial clearance 7 days after commencing treatment 
28
.  The wound was 3 years old and had failed to respond to other conventional wound 
treatments and antibiotics during the 3 year period prior to commencing the honey/antibiotic 
combination therapy. Natarajan et al (2001) treated an MRSA infected leg ulcer of an 
immunosuppressed patient with topical application of Manuka honey, consequently, MRSA 
was eradicated and the wound successfully healed 
29
. Chambers (2006) reported bacterial 
clearance in three cases of MRSA infected leg ulcers following treatment with topical 
Manuka honey whilst Visavadia et al, (2008) reported that Manuka honey, based on clinical 
experience, was now one of their first line treatments for infected wounds at the Maxillofacial 
Unit at Royal Surrey County Hospital 
30, 31
.  
Larger clinical studies have produced more controversial findings. Gethin and Cowman 
(2008) recruited 108 patients with venous leg ulcers and treated them with either Manuka 
honey or hydrogel 
32
.  In their study, Manuka honey successfully eliminated MRSA from 
70% of MRSA infected wounds, in comparison hydrogel eradicated MRSA in only 16% of 
infected wounds. For P. aeruginosa infected wounds, Manuka honey cleared infection in just 
33% of wounds and hydrogel cleared infection in 50% of wounds. Jull et al (2008) in a 
randomised clinical trial of 368 participants reported no significant difference in occurrence 
of infection in venous leg ulcers treated with either Manuka honey impregnated dressings or 
usual care 
33
. Another clinical study showed no significant difference, in terms of 
development of peritoneal dialysis related infections when patients undergoing peritoneal 
dialysis were treated with either Medihoney antibacterial wound gel (containing honey from 
Leptospermum species) or the topical antibiotic Mupirocin applied to catheter exit sites 
34
.  
ANTIMICROBIAL PROPERTIES OF HONEY: IN VIVO ANIMAL STUDIES 
Antimicrobial effects of honey have been observed in animal studies in vivo. Al-Waili (2004) 
reported that application of a natural honey from the UAE to S. aureus or Klebsiella species 
inoculated surgical wounds induced in mice, reduced the time for bacterial elimination to 
occur 
35
. Khoo et al (2010) reported that Tualang honey was superior to hydrofibre and 
hydrofibre silver dressing in reducing the growth of bacteria in P. aeruginosa inoculated burn 
wounds induced in Sprague Dawley rats 
36
. Conversely, hydrofibre and hydrofibre silver 
dressings were superior to Tualang honey in reducing bacterial growth in A. baumannii 
inoculated wounds, while, there was no significant difference between the three treatments in 
inhibiting the growth of bacteria in Klebsiella pneumonia inoculated wounds. Gunaldi et al, 
(2013) investigated the antimicrobial activity of Manuka honey in clearing MRSA infection 
in MRSA inoculated spinal implants inserted in rats 
37
. The results showed that whilst 
Manuka honey significantly reduced MRSA growth on the implants it did not eradicate the 
MRSA entirely. In the vertebral column of the rats, MRSA growth was also reduced more in 
the Manuka honey treated group compared to the control group but this was not statistically 
significant.   
It could be said that the research findings for the antimicrobial activity of honey in vivo have 
not been as ‘outstanding’ as those observed in vitro and the reasons for this require 
investigation. Human and animal cells are known to contain the enzyme catalase, an enzyme 
that breaks down hydrogen peroxide (an important antimicrobial component of some honeys) 
into hydrogen and oxygen. If the anti-microbial properties of honey are due to hydrogen 
peroxide it may be that the anti-microbial activity is reduced when honey comes into contact 
with live cells 
38
. Innovative research that can overcome obstacles associated with in vivo use 
of honey is urgently required.  
It is also important to consider that some honeys have been shown to be contaminated with 
bacteria and fungi and therefore non-γ-irradiated honeys may not be suitable for application 
on damaged skin 
23
. The production of local honeys into medical grade honeys suitable for 
use in clinical practice would be economically advantageous and beneficial to local 
communities.  
THE EFFECTS OF HONEY ON MICROBIAL PATHOGENICITY OF SKIN 
RELEVANT MICROBES: IN VITRO STUDIES 
Incredibly, recent research has shown that the antimicrobial properties of honey in vitro are 
more than bactericidal because honey has also been shown to reduce bacterial pathogenicity. 
The ability of pathogenic microbes to cause disease is partly caused by the production of 
pathogenicity factors. S. aureus, for example, produces a range of disease causing proteins 
including; catalase, haemolysin (α, β, γ and δ), epidermolytic toxins and enterotoxins. Alpha-
toxin (α-haemolysin) causes tissue damage during wound infections by creating pores in host 
cell membranes; allowing the discharge of low molecular weight compounds and by inducing 
cytokine production and apoptosis.  
Recently, Jenkins et al (2014) reported that Manuka honey reduced expression of α-toxin in 
MRSA 
39
. Expression of other virulence genes, quorum sensing genes and genes associated 
with cell division were also reduced.  Lee at al (2011) reported that three types of honey 
(Korean Acacia, Korean Polyfloral and American Clover honey) at concentrations as low as 
0.5% significantly inhibited pathogenic E. coli O157:HA biofilm formation in vitro 
40
. 
Furthermore, low concentrations of the Korean acacia honey reduced the expression of curli 
genes (csgBAC), quorum sensing genes (AI-2 importer, indole biosynthesis) and virulence 
genes (LEE genes) in the bacterial strain. Kronda et al (2013) reported that sublethal 
concentrations of Manuka honey reduced siderophore production, a virulence factor that 
scavenges iron for bacterial growth, in clinical and non-clinical strains of P. aeruginosa 
41
. 
Manuka honey has also been shown to alter the structure of P. aeruginosa; scanning and 
transmission electron microscopy revealed changes in cell shape and cell lysis following 
incubation with honey 
42
. A honey flavonoid extract was also found to alter membrane 
integrity and branching processes associated with virulence in C. albicans 
43
.  
As well as the more commonly investigated wound pathogens, sub-inhibitory concentrations 
of Manuka Honey and Slovakian honeys (Hawthorn, Honeydew and Acacia) significantly 
inhibited Proteus mirabilis and Enterobacter cloacae biofilm formation in vitro 
44
. 
In vivo studies investigating the efficacy of sub-lethal concentrations of honeys against 
biofilms would advance our knowledge of the ability of honey to modulate bacterial 
pathogenicity.   
ANTIMICROBIAL MODE OF ACTION OF HONEY 
The anti-microbial properties of honey have been attributed to multiple components including 
high sugar concentration, low pH, hydrogen peroxide (H2O2), methylglyoxal (MGO), anti-
microbial peptide bee defensin-1 and other compounds such as polyphenols that have not 
been fully elucidated.   
The high sugar concentration and low moisture content of honey causes osmotic stress to 
microbial cells and low pH is unfavourable for the growth of many micro-organisms. 
However, if a sugar solution with identical sugar components and pH to that of honey is 
prepared the antimicrobial activity of the sugar solution is often considerably lower than that 
of honey suggesting that other factors in the honey are responsible for its antimicrobial 
activity 
23
.   
Honey bees add an enzyme called glucose oxidase to the collected nectar during the honey 
making process which converts the glucose in the honey into hydrogen peroxide (H2O2) and 
gluconic acid. H2O2 is toxic to many microbes. During the ripening of honey glucose oxidase 
is inactivated but regains its activity if the honey is diluted. In a study by Kwakman et al 
(2011) it was found that Revamil honey produced 3.47± 0.25 mM H2O2 in 40% (v/v) honey 
after 24 hours but no H2O2 was detectable in the Manuka honey they tested suggesting that 
non-peroxide factors are responsible for the antimicrobial activity of Manuka honey 
10
.  
Manuka honey has been shown to contain high levels of methylglyoxal (MGO); 44 fold 
higher than Revamil. MGO in Manuka honey is produced by the non-enzymatic conversion 
of dihydroxyacetone (DHA) present at high concentrations in the nectar of L. scoparium 
flowers. The change occurs slowly during honey storage. Kwakman et al (2011) reported that 
neutralisation of MGO in Manuka honey abolished the antimicrobial activity of the honey 
against S. aureus but did not abolish the antimicrobial activity against E. coli and P. 
aeruginosa 
10
. The authors concluded that MGO is not fully responsible for Manuka honeys 
non peroxide antimicrobial activity and that other components possibly polyphenols may be 
responsible. 
Polyphenols derived from plant nectar are natural organic chemicals characterised by the 
presence of multiple phenol structural units. Many are antioxidants e.g. flavonoids.  The 
antibacterial properties of flavonoids have been attributed to inhibition of bacterial energy 
metabolism, bacterial DNA gyrase and cytoplasmic membrane function 
45
. Researchers in 
New Zealand identified the polyphenol methyl syringate as the major component of the 
phenolic fraction of Manuka Honey 
46
. A novel glycoside of methyl syringate, named 
leptosin, was recently identified in Manuka honey and levels were found to correlate 
positively with the UMF 
47
. Identification of phenolic compounds in honey may be important 
for the production of new antimicrobials and therefore the analysis of the phenolic profile of 
active honeys should be encouraged. Combinations of polyphenols may be more effective as 
they may act synergistically to inhibit microbial growth or structural alteration of individual 
polyphenols could be employed to enhance antimicrobial activity.   
Bee defensin-1 is an anti-microbial peptide that is part of the honey bee innate immune 
system. It is secreted by the honey bee hypopharyngeal gland and can enter honey via bee 
saliva during the regurgitation process of honey making. Bee defensin-1 has strong activity 
against gram positive bacteria including S. aureus. Kwakman and Zaat (2010) identified Bee 
defensin-1 in Revamil honey but not Manuka honey 
48
.   
Raw honey may also contain propolis; a substance composed of plant resins and used by bees 
to seal the hive. Scientific research has shown that propolis has antimicrobial properties 
49
. 
The research of Kwakman et al demonstrates the diversity and complexity of the 
antimicrobial components of different types of honey. Analysis of the antimicrobial 
components of other active honeys will be important for a fuller understanding of their 
applicability to medicine. 
CONCLUSIONS  
It can be concluded from in vitro studies that honey has powerful antimicrobial activity 
against dermatologically relevant microbes. These findings are particularly promising in 
current times when the problem of antimicrobial drug resistance is considered a global crisis 
and the World Health Organisation (2014) has acknowledged the possibility of a post 
antibiotic era where common infections kill. Even more exciting are the in vitro findings that 
honey can reverse antimicrobial resistance and reduce microbial pathogenicity. Despite these 
optimistic findings in vitro, the use of honey in clinical practice today as an antimicrobial 
agent does not appear to have yet reached its potential. Innovative research that can 
maximally exploit the antimicrobial properties of this natural substance and overcome 
obstacles associated with in vivo use may in the future lead to the production of an 
antimicrobial agent that is highly valued in clinical practice. Interestingly, no honey resistant 
microbial strains have emerged to date and this may be unlikely because of the multifactorial 
nature of the antimicrobial properties of honey.  As honeys from diverse floral origins have 
been shown to have antimicrobial activity against a range of skin relevant microbes research 
should continue to investigate the efficacy of honey in the treatment of other types of skin 
disorders where microbes have been implicated in the pathophysiology of the disease. There 
are countless varieties of honey being produced worldwide and some may have superior anti-
microbial activities that are yet to be discovered.   
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